Rhinitis-Impfstoff für Pferde

European patent · EP2772266 · In force

Register entry

Publication number
EP2772266
Application number
EP14164842
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 12, 2012
Published
Sep 3, 2014
Granted
Jul 31, 2019
Protection ends at the latest
Mar 11, 2032
Next annual fee due
Mar 31, 2027
IPC classes
A61K 39/125 (2006.01)
A61K 39/145 (2006.01)
A61K 39/245 (2006.01)
A61P 11/00 (2006.01)
Priority
US 201161452390 P 14.03.2011
US 201161510226 P 21.07.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. Jul 31, 2019

    Granted

    Published in Swissreg on 31.07.2019

Parties

Holder

Boehringer Ingelheim Animal Health USA Inc.

3239 Satellite Blvd, Duluth, GA 30096, US

Inventor

Hayes, Phillip Wayne

St Joseph, MO Missouri 64506, US

Viel, Laurent

Rockwood, Ontario NOB 2K0, CA

Diaz-Mendez, Andrés

Dundas, Ontario L9H 5E1, CA

Hennessy, Kristina J.

Shawnee, KS Kansas 66216, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.